The following study has recently been activated for patient enrollment by The University of Illinois Cancer Center Clinical Trials Office (CTO). Click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, email [email protected] or call 312-355-5112.
Sponsor: Novartis Pharmaceuticals
Principal Investigator: Kent Hoskins, MD